Table 3

Survival analyses of prognostic factors in ENKTL
Variable p value
Gender
 Male versus Female 0.0658
Age (years)
 ≤40y versus >40y 0.8679
Ann Arbor Stage
 Stage I, II versus Stage III, IV 0.4129
LDH level
 High versus Normal 0.7703
B symptoms
 Positive versus Negative 0.0180*
IPI
 L/LI versus HI/H 0.5418
Treatment
 Single therapy versus Combined therapy 0.0082*
LMP1 expression
 Positive versus Negative 0.0201*
LMP2A expression
 Positive versus Negative 0.0487*

LDH: lactate dehydrogenase; IPI: international prognostic index.

L: low risk; LI: low-intermiediate risk; HI: high-intermiediate risk.

* P < 0.05.

Mao et al.

Mao et al. Diagnostic Pathology 2012 7:178   doi:10.1186/1746-1596-7-178

Open Data